Skip to main content
. 2021 May 19;3(5):e0438. doi: 10.1097/CCE.0000000000000438

TABLE 1.

Patients Characteristics on Hospital Admission, Evolution and Treatment During the First and the Second Waves of Coronavirus Disease 2019 Pandemic

Variables First Wave of the COVID-19 Pandemic Number of Patients Second Wave of the COVID-19 Pandemic Number of Patients p
Age (yr) 68 (57–80) 341 71 (60–80) 662 0.15
Body mass index (kg/m2) 27.2 (24–31) 257 27.0 (24–31) 509 0.054
Sex (male) 200 (59%) 341 386 (58%) 662 0.92
Chronic kidney disease 37 (10.9%) 341 66 (10%) 662 0.66
Diabetes 125 (37%) 341 283 (43%) 662 0.063
Hypertension 181 (53%) 341 322 (49%) 662 0.18
Bilirubin (mg/dL) 0.68 (0.5–0.97) 336 0.64 (0.48–0.9) 640 0.14
C-reactive protein (mg/L) 81.8 (33.6–166) 339 78.2 (29.0–146) 645 0.15
Creatinine (mg/dL) 0.99 (0.81–1.35) 338 0.99 (0.77–1.38) 644 0.68
d-dimer (ng/mL) 924 (540–1,782) 297 1,020 (576–2,004) 552 0.13
Ferritin (µg/L) 1,003 (531–2,329) 77 743 (327–2,017) 189 0.041
Lymphocyte count (103/mm3) 0.94 (0.66–1.23) 337 0.90 (0.63–1.31) 644 0.51
Platelet count (103/mm3) 195 (155–263) 337 209 (161–274) 644 0.15
Spo2 (%) 94 (90–96) 340 93 (90–96) 658 0.53
Respiratory rate (/min) 22 (19–29) 325 20 (18–25) 575 0.0003
Heart rate (/min) 90 (79–103) 341 88 (76–101) 662 0.15
Mean arterial pressure (mm Hg) 94.0 (86.0–103) 341 94.3 (83.6–105) 662 0.48
Viral load (cycle threshold) 27.5 (23–31) 279 26.5 (21–32) 454 0.91
Hyrdoxychloroquine 249 (73%) 341 0 (0%) 662 <0.0001
Remdesivir 2 (0.6%) 341 88 (13.3%) 662 <0.0001
Dexamethasone 11 (3.2%) 341 404 (61%) 662 <0.0001
Transfer in ICU 87 (26%) 341 128 (19%) 662 0.024
30-d mortality 74 (22%) 341 99 (15%) 662 0.007
Age of deceased patients (yr) 79.5 (71–86) 74 82 (74–88) 99 0.069

COVID-19 = coronavirus disease 2019.

Quantitative variables are reported as median (Q1–Q3) and categorical variables as number (%). Kruskal-Wallis and Fisher exact tests are used as appropriate.